Raloxifene reduces risk positive to a hormone of a cancer of a mammary gland and crises “without a doubt shade,” but its effects on cardiovascular illness remain less indisputable, according to results “Raloxifene for Heart Use” (РУТ) the research published in a problem on July, 13th of 2006 Magazines of New England of Medicine by the doctor of Elizabeth Barrett-Connor (university of California in San Diego) and colleagues. (далее…)

Raloxifene can reduce risk of a cancer of a mammary gland, especially among women with the family case record.
Raloxifene it was used to prevent back crises among concerning the period after менопаузы women with osteoporosis. It also thought to have some protective effect against a mammary gland cancer, and it has been checked up in MORE (Repeated Results of Estimation Raloxifene) test; it has shown 72 percent reduction of aggressive level of a cancer of a mammary gland after four years of processing, against плацебо. Test has been expanded within even four years, and it has shown that processing of eight years has been connected with 66 percent reduction in risk of a cancer of a mammary gland. (далее…)